// App-Quantinova.ai

1303 : Tumor Suppressors BTG1 and BTG2 Fulfill Both Unique and Overlapping Functions During Normal B Lymphocyte Development

Researchers

Presenter

  • Liesbeth van Emst

Principal Investigators

  • Jorn Havinga

  • Jean-Pierre Rouault

  • Felice Tirone

  • Peter M. Hoogerbrugge

  • Blanca Scheijen

  • Frank N. van Leeuwen

Medical Centers

  • Institute of Neurobiology and Molecular Medicine-Consiglio Nazionale delle Ricerche, Rome, Italy

  • Institut de Genomique Fonctionnelle de Lyon, Ecole Normale Superieure de Lyon, Lyon, France

  • Experimential Rheumatology, Radboud university medical center, Nijmegen, Netherlands

Locations

  • France

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Paired box 5

  • Cluster of differentiation 45

  • Protein Arginine Methyltransferase 1

  • Cyclin Dependent Kinase Inhibitor 2A

  • Retinoblastoma protein

  • ETV6-RUNX1

  • Interleukin-7

Drug/Treatment

  • Interleukin

  • Arginine hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved